GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 99 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $69,000 | +4.5% | 10,600 | -21.8% | 0.00% | – |
| Q4 2018 | $66,000 | -51.5% | 13,550 | -27.0% | 0.00% | – |
| Q3 2018 | $136,000 | +15.3% | 18,550 | 0.0% | 0.00% | – |
| Q2 2018 | $118,000 | +24.2% | 18,550 | +5.7% | 0.00% | – |
| Q1 2018 | $95,000 | +72.7% | 17,550 | +32.5% | 0.00% | – |
| Q4 2017 | $55,000 | -81.2% | 13,250 | -56.3% | 0.00% | -100.0% |
| Q3 2017 | $292,000 | +39.0% | 30,350 | +71.0% | 0.00% | – |
| Q2 2017 | $210,000 | – | 17,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|